NCPA’s recommendations for improving the “increasingly complicated Part D marketplace.”
A new campaign takes aim at drug prices, but is it the right approach?
Did major chain pharmacies and distributors contribute to the opioid epidemic in Oklahoma?
Anthem is parting ways with Express Scripts.
DIR fees top pharmacy legislator meetings.
Community pharmacists fight against financial pressure for their survival.
How the new Trump administration will affect everything from the ACA to the FDA.
Drug Topics readers weigh in